Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis.
Kizilisik
T A
TA
Department of Surgery, University of Alberta Hospitals, Edmonton, Canada.
Preiksaitis
J K
JK
Kneteman
N M
NM
D000212:Acyclovir / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000503:physiopathology / Q000517:prevention & control*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology; D011183:Postoperative Complications / Q000382:microbiology / Q000517:prevention & control*; D013997:Time Factors
D007166:Immunosuppressive Agents; D000212:Acyclovir